Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02588690 · ClinicalTrials.gov registry record
Beauty from Within Community Screening Project
A clinical trial of Heart Health Screening and Prevention, sponsored by Cedars-Sinai Medical Center.
- Active
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02588690: Active study of Heart Health Screening and Prevention, sponsored by Cedars-Sinai Medical Center.
NCT02588690 is a study of Heart Health Screening and Prevention that is active but no longer recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02588690, a study of Heart Health Screening and Prevention, is active but no longer recruiting, sponsored by Cedars-Sinai Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease (CVD) is the leading cause of death world-wide in women. Despite current medical advances, heart disease is rising in relatively young women. Women access primary care differently than men, most utilizing their Obstetrics-gynecology clinic for primary care services. The recent implementation of the Affordable Care Act (ACA) aims to provide increased access to primary care services, however, women are still not appropriately risk stratified for CVD disease risk. Many women still are not aware that they are at risk for CVD. This is particularly true for the 15-44 year old female age group. Lack of proper risk stratification may be related to women not being properly identified or appropriately referred to preventive cardiovascular services for treatment of traditional risk factors such as diabetes, obesity, hypertension, and dyslipidemia. These traditional risk markers serve as examples of chronic diseases, which are not always recognized in the early stages and therefore not optimally managed. Furthermore, if women are not feeling ill, they are less likely to access their current primary care resources for preventive strategies. Investigators propose to risk stratify women in places where they usually congregate. In addition to convenience, current risk stratification is improved with the recent implementation of the ASCVD risk calculator. Investigators hypothesize that if women were properly risk stratified and referred to appropriate preventive cardiovascular risk clinics, more preventive strategies could be implemented, therefore reducing the amount of unnecessary premature disease in women. To achieve this ambitious goal, investigators propose a three step, demonstration project. The specific aims of this proposal is to: 1. Provide women with CVD risk stratification in places where they locally convene on a daily basis. 2. To evaluate the efficacy of a lay professional to adequately assess CVD risk. 3. To evaluate if assessment of CVD ris
Primary Outcome
Comparing ASCVD Risk Score calculated during initial visit and a score calculated in one year.
Conditions Studied
Interventions
- PROCEDURE Fingerstick cholesterol test
- OTHER Atherosclerosis Cardiovascular Disease Risk assessment
- PROCEDURE Blood pressure measurement
Study Locations (1)
California
- Cedars-Sinai Women's Heart Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-11 |
| Est. Completion | 2030-11 |
What the registry record for NCT02588690 still lists
NCT02588690 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Heart Health Screening and Prevention appearing as the primary indexed condition, and to 3 interventions - of which Fingerstick cholesterol test is the first listed.
NCT02588690 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02588690 about?
NCT02588690 is a clinical study titled "Beauty from Within Community Screening Project". Cardiovascular disease (CVD) is the leading cause of death world-wide in women. Despite current medical advances, heart disease is rising in relatively young women. Women access primary care differently than men, most utilizing their Obstetrics-gynecology clinic for primary care services. The recent...
What is the current status of trial NCT02588690?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2015-11. Estimated completion is 2030-11.
What conditions does trial NCT02588690 study?
This clinical trial studies the following conditions: Heart Health Screening and Prevention.
What interventions are being tested in trial NCT02588690?
The interventions under investigation include: Fingerstick cholesterol test (PROCEDURE), Atherosclerosis Cardiovascular Disease Risk assessment (OTHER), Blood pressure measurement (PROCEDURE).
Who is sponsoring clinical trial NCT02588690?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02588690 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia